Duration of dual anti-platelet therapy – State of the art after the DAPT and PEGASUS-TIMI 54 trials
Sign Up to like & getrecommendations! Published in 2017 at "Acta Cardiologica"
DOI: 10.1080/00015385.2017.1305189
Abstract: Abstract Dual anti-platelet therapy is prescribed in the setting of coronary heart disease for the prevention of stent thrombosis and acute thrombotic events. The optimal duration of dual anti-platelet therapy is still under debate as… read more here.
Keywords: anti platelet; dual anti; platelet therapy; duration dual ... See more keywords
Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "Anatolian Journal of Cardiology"
DOI: 10.14744/anatoljcardiol.2017.7672
Abstract: Objective: There has been much debate regarding the optimal duration of dual antiplatelet therapy (DAPT) cover after drug eluting stent (DES) implantation. We aimed to assess the relative benefits of shorter and longer durations of… read more here.
Keywords: drug eluting; optimal duration; duration dual; dual antiplatelet ... See more keywords
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cardiovascular medicine"
DOI: 10.2459/jcm.0000000000000434
Abstract: Definition of the optimal duration of dual anti-platelet therapy (DAPT) is an important clinical issue, given the large number of patients having percutaneous coronary intervention (PCI), the costs and risks of pharmacologic therapy, the consequences… read more here.
Keywords: risk; cardiology; optimal duration; duration dual ... See more keywords